In addition, a number of similarities between this AD animal model and human AD have been documented, including loss of synaptic markers observed at 9 months, cognitive impairment as early as 4 months12,13, and association of the AD-specific enzyme butyrylcholinesterase (BChE) with β-amyloid pathology14,15. The gene discussed is BCHE; the disease is Cognitive impairment.